Status:
ACTIVE_NOT_RECRUITING
Markers of Oxidative Stress in Inflammatory Bowel Diseases: Risk Factors and Implications for a Dietetic Approach
Lead Sponsor:
Università Politecnica delle Marche
Collaborating Sponsors:
Ministry of Health, Italy
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
6-80 years
Phase:
NA
Brief Summary
Inflammatory bowel disease (IBD), including Crohn's disease (CD), Ulcerative Colitis (UC) and IBD-unclassified (IBD-U) is a chronic inflammatory intestinal disorders that affect both children and adul...
Detailed Description
IBD is a complex disorder that is thought to be the result of an aberrant immune response to commensal bacteria in a genetically susceptible host. The chronic inflammation along the gastrointestinal t...
Eligibility Criteria
Inclusion
- \- Diagnosis of IBD
Exclusion
- permanent stoma
- cancer
- cardiovascular disease
- ischemic disease
- Alzheimer's disease
- type 2 diabetes
Key Trial Info
Start Date :
December 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 8 2024
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT04513015
Start Date
December 15 2019
End Date
December 8 2024
Last Update
December 9 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
SOD Clinica Pediatrica, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona
Ancona, Italy, 60123
2
SOD Clinica di Gastroenterologia, Epatologia ed Endoscopia Digestiva, Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona
Ancona, Italy, 60126